Skip to content Skip to navigation

The Economics of the Public Option: Evidence from Local Pharmaceutical Markets

Oct 2021
Working Paper
By  Juan Pablo Atal, José Ignacio Cuesta, Felipe González, Cristobal Otero

We study the effects of competition by state-owned firms, leveraging the decentralized entry of public pharmacies to local markets in Chile. Public pharmacies sell the same drugs at a third of private pharmacy prices, because of stronger upstream bargaining and downstream market power in the private sector, but are of lower quality. Public pharmacies induced market segmentation and price increases in the private sector, benefiting the switchers to the public option but harming the stayers. The countrywide entry of public pharmacies would reduce yearly consumer drug expenditure by 1.6 percent, which outweighs the costs of the policy by 52 percent.

Publication Keywords: 
state-owned firms